New EU Guidance To Boost Development Of Vaccines And Treatments For RSV Infections

 
• By Ian Schofield

Companies wanting more guidance on how to go about developing new vaccines and treatments for respiratory syncytial viral infections will be interested in a new document that has just been put out for consultation by the European Medicines Agency.

Lung
New EU guideline aims to boost R&D into RSV infections.

More from Vaccines

More from Pink Sheet